Is Sildenafil Neutral on Cardiopulmonary Performance in Group 2 Pulmonary Hypertension? More Details for Interpretation

European Journal of Heart Failure - United States
doi 10.1002/ejhf.753
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cardiopulmonary Hemodynamics in Pulmonary Hypertension: Pressure Tracings, Waveforms, and More

Advances in Pulmonary Hypertension
2008English

Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Current Practices on the Use of Sildenafil Citrate for Pulmonary Arterial Hypertension in Brazilian Hospitals

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2009English

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

Long-Term Treatment With Sildenafil in Chronic Thromboembolic Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Sildenafil Therapy in Patients With Sickle Cell Disease and Pulmonary Hypertension

British Journal of Haematology
Hematology
2005English

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2014English

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy